Histopathology & Cytology in Algeria
Engineering Excellence & Technical Support
Histopathology & Cytology solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
AI-Powered Diagnostic Advancement
Algerian histopathology and cytology labs are increasingly integrating Artificial Intelligence (AI) for enhanced diagnostic accuracy. AI algorithms are being trained on vast datasets to identify subtle cellular anomalies in biopsies and cytological samples, accelerating diagnosis for conditions like cancer and inflammatory diseases, thereby improving patient outcomes and optimizing pathologist workloads.
Molecular Pathology Integration
The adoption of molecular pathology techniques is revolutionizing histopathology and cytology in Algeria. Advanced molecular tests, such as next-generation sequencing (NGS) and in-situ hybridization (ISH), are becoming more accessible. These techniques allow for the precise identification of genetic mutations and biomarkers, guiding personalized treatment strategies and improving the prognostication of various diseases.
Telepathology Network Expansion
To address geographical disparities and enhance expert consultation, Algeria is actively expanding its telepathology networks. This involves the digital archiving of slides and real-time remote review by specialized pathologists. This initiative significantly improves access to subspecialty expertise, especially in remote regions, ensuring consistent quality of diagnostic services across the country.
What Is Histopathology & Cytology In Algeria?
Histopathology and Cytology are crucial diagnostic disciplines within anatomical pathology that involve the microscopic examination of tissues and cells, respectively, to identify disease processes. In Algeria, these services are integral to the healthcare system, providing essential information for diagnosis, prognosis, and treatment planning across a broad spectrum of medical conditions. Histopathology focuses on the study of diseased tissue biopsies and surgical resections, while Cytology examines individual cells or small clusters of cells obtained from various body sites. The interpretation of these specimens is performed by qualified pathologists who analyze cellular morphology, architectural patterns, and immunohistochemical markers to reach a definitive diagnosis. This service is indispensable for oncology, inflammatory disorders, infectious diseases, and the evaluation of organ transplantation, playing a pivotal role in patient management and public health surveillance.
| Service Component | Description | Indication/Need | Typical Use Cases in Algeria |
|---|---|---|---|
| Histopathology | Microscopic analysis of fixed and processed tissue samples. | Suspicion or diagnosis of solid tumors, inflammatory conditions, infectious diseases affecting tissues, and evaluation of organ transplant rejection. | Biopsies of skin lesions, gastrointestinal tract polyps/tumors, breast lumps, lymph nodes, liver biopsies, kidney biopsies, surgical resection margins. |
| Cytology | Microscopic analysis of dispersed cells obtained from various sources. | Screening for cervical cancer, evaluation of effusions (pleural, peritoneal, pericardial), aspiration of superficial or deep lesions, examination of urine and sputum. | Pap smears (cervical cytology), Fine Needle Aspiration (FNA) of thyroid nodules, breast masses, lymph nodes, examination of pleural fluid for malignancy, urine cytology for bladder cancer detection. |
| Special Stains & Immunohistochemistry | Application of specific chemical stains or antibody-based detection methods to highlight cellular components or protein expression. | Differential diagnosis of poorly differentiated tumors, identification of infectious agents, prognostication, and prediction of therapeutic response. | Detecting specific tumor markers (e.g., ER, PR, HER2 in breast cancer), identifying pathogens (e.g., Helicobacter pylori), differentiating tumor types (e.g., lymphoma, sarcoma). |
| Molecular Pathology (Emerging) | Analysis of genetic material within cells or tissues. | Identification of specific genetic mutations for targeted therapy, molecular subtyping of cancers, and prognostic assessment. | EGFR mutation testing in lung cancer, BRAF mutation testing in melanoma, HER2 amplification analysis in breast cancer. |
Key Aspects of Histopathology and Cytology Services in Algeria
- Microscopic examination of tissue biopsies and surgical specimens (Histopathology).
- Microscopic examination of exfoliated or aspirated cells (Cytology).
- Diagnosis of neoplastic and non-neoplastic diseases.
- Assessment of disease grading and staging.
- Guidance for therapeutic interventions.
- Screening for precancerous lesions (e.g., Pap smears).
- Monitoring of treatment response.
- Support for research and epidemiological studies.
Who Needs Histopathology & Cytology In Algeria?
Histopathology and cytology are indispensable diagnostic tools in Algeria, offering crucial insights into disease diagnosis, prognosis, and treatment planning. Their applications span across numerous medical disciplines, making them vital for healthcare providers and researchers alike. These services are fundamental for accurate disease characterization, particularly in oncology, infectious diseases, and inflammatory conditions, thereby guiding clinical decisions and improving patient outcomes.
| Department/Specialty | Primary Use of Histopathology & Cytology | Key Applications/Examples |
|---|---|---|
| Oncology | Cancer diagnosis, staging, grading, and monitoring of treatment response. | Biopsies of tumors (breast, lung, colon, etc.), Pap smears for cervical cancer screening, FNAC (Fine Needle Aspiration Cytology) of suspicious lumps. |
| Pathology | The central hub for tissue and cell analysis, providing definitive diagnoses. | Microscopic examination of biopsies and surgical resections, preparation and analysis of cytology samples. |
| Internal Medicine | Diagnosis and management of a wide range of diseases, including infections and inflammatory conditions. | Liver biopsies for hepatitis, kidney biopsies for nephritis, pleural fluid cytology for effusions. |
| Dermatology | Diagnosis of skin lesions, including benign and malignant conditions. | Skin biopsies for melanoma, basal cell carcinoma, squamous cell carcinoma, and inflammatory dermatoses. |
| Gynecology & Obstetrics | Screening and diagnosis of gynecological cancers and infections. | Pap smears, endometrial biopsies, ovarian cyst aspirates. |
| Pulmonology | Diagnosis of lung diseases, including infections, inflammation, and cancer. | Bronchial brushing cytology, pleural fluid cytology, lung biopsies. |
| Gastroenterology | Diagnosis of gastrointestinal diseases, including inflammatory bowel disease and cancers. | Endoscopic biopsies of the esophagus, stomach, and colon, stool cytology. |
| Urology | Diagnosis of genitourinary tract cancers and infections. | Prostate biopsies, bladder biopsies, urine cytology. |
| Hematology | Diagnosis and classification of blood disorders, including leukemias and lymphomas. | Bone marrow biopsies and aspirates, lymph node biopsies. |
| Infectious Diseases | Identification of pathogens and assessment of tissue response to infection. | Biopsies of infected organs, examination of bodily fluids for microorganisms. |
| Forensic Medicine | Investigation of cause of death and identification of injuries. | Autopsy tissue analysis. |
| Research & Academia | Understanding disease mechanisms, developing new diagnostic markers, and evaluating experimental therapies. | Tissue and cell samples for various research projects. |
Target Customers and Departments in Algeria
- Hospitals (Public and Private)
- University Hospitals & Medical Schools
- Specialized Clinics (e.g., Oncology, Dermatology, Gynecology)
- Research Institutions
- Public Health Laboratories
Histopathology & Cytology Process In Algeria
The histopathology and cytology process in Algeria, like in many countries, follows a structured workflow to ensure accurate diagnosis and patient care. This process begins with an inquiry from a clinician, leading to sample collection, transportation to the laboratory, processing, examination, and finally, the generation of a report. Throughout this workflow, quality control measures are essential to maintain the integrity and reliability of the results. The specific implementation and available resources can vary between public and private healthcare facilities, as well as urban and rural settings, but the core steps remain consistent.
| Stage | Description | Key Activities | Responsible Personnel |
|---|---|---|---|
| Inquiry & Order | Clinician identifies a need for diagnostic testing. | Clinical assessment, test requisition. | Clinician |
| Sample Collection | Acquisition of biological material. | Biopsy, aspiration, scraping, fluid collection, proper labeling. | Clinician, Nurse, Technician |
| Sample Transportation | Movement of sample to the laboratory. | Appropriate packaging, temperature control, courier service. | Courier, Laboratory Staff |
| Accessioning | Registration and tracking of samples. | LIS entry, unique identification, verification. | Laboratory Technician, Administrative Staff |
| Histopathology Processing | Preparation of tissue for microscopic viewing. | Fixation, grossing, dehydration, embedding, sectioning, staining. | Pathologist, Histotechnician |
| Cytology Processing | Preparation of cellular samples for microscopic viewing. | Smear preparation, LBC, centrifugation, cell block, fixation, staining. | Cytotechnologist, Pathologist |
| Microscopic Examination | Evaluation of slides under microscope. | Morphological assessment, identification of abnormalities. | Pathologist, Cytotechnologist |
| Diagnosis & Reporting | Formulation and documentation of findings. | Pathological interpretation, report writing. | Pathologist |
| Report Dissemination | Communication of results to the clinician. | LIS report, printed copy, direct communication. | Laboratory Staff, Clinician |
| Archiving | Storage of slides and blocks. | Secure storage, retrieval system. | Laboratory Staff |
| Quality Control | Ensuring accuracy and reliability. | Calibration, proficiency testing, internal reviews. | All Laboratory Staff |
Histopathology & Cytology Workflow in Algeria
- Clinician Inquiry & Test Order: The process initiates when a clinician suspects a condition requiring histopathological or cytological examination (e.g., suspected malignancy, inflammatory conditions). They formally order the test, specifying the type of sample needed and the clinical question.
- Sample Collection: Based on the clinician's order, the appropriate sample is collected. This can range from tissue biopsies (surgical specimens, needle biopsies) for histopathology to cellular material (smears, fluids) for cytology. Proper labeling with patient demographics and clinical history is crucial.
- Sample Transportation: Samples are transported from the collection site to the histopathology/cytology laboratory. This requires appropriate containers, temperature control (if necessary), and secure handling to prevent degradation or contamination.
- Laboratory Accessioning: Upon arrival at the lab, each sample is registered in a Laboratory Information System (LIS). This involves assigning a unique accession number, verifying patient details, and logging the date and time of receipt.
- Histopathology Processing:
- Fixation: Tissue samples are immediately placed in a fixative (commonly formalin) to preserve cellular structure and prevent autolysis.
- Grossing: A pathologist or trained technician examines the specimen macroscopically, describing its size, color, texture, and any visible abnormalities. Representative sections are selected for further processing.
- Tissue Processing (Dehydration & Embedding): Selected tissue sections are dehydrated through a series of alcohol solutions, cleared with a solvent, and then embedded in paraffin wax to create a solid block. This allows for thin sectioning.
- Sectioning (Microtomy): The paraffin block is cut into very thin sections (typically 2-5 micrometers) using a microtome.
- Staining: The thin sections are mounted on glass slides and stained using various dyes (most commonly Hematoxylin and Eosin - H&E) to visualize cellular components and structures.
- Special Stains & Immunohistochemistry (IHC): Depending on the clinical suspicion, special stains or IHC may be performed to highlight specific cellular components, pathogens, or markers (e.g., for tumor typing).
- Cytology Processing:
- Smear Preparation: Direct smears are made from cellular samples (e.g., cervical Pap smears, fine needle aspirates).
- Liquid-Based Cytology (LBC): In some facilities, samples are collected into a preservative fluid, which is then processed to create a cleaner, more standardized slide.
- Centrifugation & Cell Block Preparation: For fluid samples, cells are concentrated by centrifugation, and sometimes a cell block is created for better histological correlation.
- Fixation & Staining: Cytological preparations are fixed and stained (e.g., Papanicolaou stain - Pap stain for gynecological samples, or May-Grünwald-Giemsa for non-gynecological samples).
- Microscopic Examination: A qualified pathologist or cytotechnologist examines the stained slides under a microscope. They meticulously evaluate cellular morphology, identify any abnormal cells or features, and assess the overall tissue architecture.
- Diagnosis & Report Generation: Based on the microscopic findings, the pathologist arrives at a diagnosis. This is then documented in a formal histopathology/cytology report, which includes a detailed description of findings, the diagnosis, and often recommendations for further management.
- Report Dissemination: The final report is communicated back to the requesting clinician, usually through the LIS or a physical copy.
- Archiving: Processed slides and paraffin blocks are archived for future reference, legal purposes, or further studies.
- Quality Control & Assurance: Throughout the entire process, strict quality control measures are implemented, including regular calibration of equipment, proficiency testing, internal review of slides, and adherence to standardized protocols.
- Interdisciplinary Consultation: In complex cases, pathologists may consult with other specialists (e.g., oncologists, surgeons) to discuss findings and guide patient management.
Histopathology & Cytology Cost In Algeria
Histopathology and cytology services in Algeria are subject to a range of costs influenced by several factors. The primary determinant is the complexity of the test, with routine screenings generally being more affordable than specialized analyses requiring extensive sample processing or advanced diagnostic techniques. The type of sample collected (e.g., biopsy, fine-needle aspirate, Pap smear) also plays a role in the overall cost. Furthermore, the reputation and accreditation of the laboratory or clinic, the geographical location within Algeria (major cities might have slightly higher pricing due to overhead), and the inclusion of pathologist consultation fees all contribute to the final price. While specific pricing can fluctuate, it's important to note that these services are generally accessible to the Algerian population, with many healthcare providers offering competitive rates. It is advisable to obtain direct quotes from multiple reputable laboratories for accurate and up-to-date pricing.
| Service Type | Estimated Price Range (Algerian Dinar - DZD) |
|---|---|
| Routine Cytology (e.g., Pap Smear) | 5,000 - 15,000 |
| Fine-Needle Aspiration (FNA) Cytology (Simple) | 8,000 - 20,000 |
| Histopathology (Small Biopsy, routine processing) | 10,000 - 25,000 |
| Histopathology (Larger Biopsy/Complex specimen) | 15,000 - 40,000+ |
| Specialized Stains/Immunohistochemistry (per stain) | 5,000 - 15,000 |
| Pathologist Consultation Fee (if separate) | 3,000 - 10,000 |
Key Factors Influencing Histopathology & Cytology Costs in Algeria:
- Complexity of the diagnostic test (e.g., routine vs. specialized analysis).
- Type of sample collected (biopsy, FNA, Pap smear, etc.).
- Laboratory's reputation, accreditation, and overhead costs.
- Geographical location within Algeria (urban vs. rural areas).
- Inclusion of pathologist's consultation and report fees.
- Urgency of the test (expedited services may incur higher charges).
Affordable Histopathology & Cytology Options
Navigating the costs of histopathology and cytology services can be a significant concern for healthcare providers and patients. Fortunately, various strategies exist to make these essential diagnostic services more affordable without compromising quality. This section explores value bundles and effective cost-saving approaches.
| Strategy | Description | Potential Cost Savings |
|---|---|---|
| Value Bundles | Pre-defined packages of related services offered at a discounted rate compared to purchasing them individually. Examples include basic screening bundles, specific disease diagnostic pathways, or comprehensive pathology reports for surgical resections. | Significant, as they offer economies of scale and predictable pricing for common diagnostic needs. |
| Negotiating Volume Discounts | Establishing long-term contracts or partnerships with laboratories in exchange for guaranteed patient volume can lead to lower per-case pricing. | Can be substantial, especially for high-volume practices or hospitals. |
| Telepathology and Digital Pathology | Utilizing digital scanning of slides and remote expert consultation can reduce the need for physical slide transport, specialized personnel on-site, and potentially faster turnaround times. | Reduces courier costs, infrastructure investment, and can improve workflow efficiency. |
| Efficient Specimen Processing | Implementing standardized protocols for specimen collection, labeling, and transport minimizes errors, re-runs, and unnecessary costs. Proper fixation and handling can prevent specimen degradation. | Reduces waste, repeat testing, and the costs associated with specimen rejection. |
| Appropriate Test Utilization | Ensuring that requested tests are clinically indicated and that less expensive but equally diagnostic alternatives are considered first. | Avoids unnecessary advanced or specialized testing, directly impacting per-case costs. |
| Consolidated Reporting | Many labs offer options for consolidated billing and reporting for multiple specimens from the same patient or procedure, simplifying administrative overhead. | Reduces administrative burden and potential for billing errors. |
Key Cost-Saving Strategies for Histopathology & Cytology
- Understanding Value Bundles
- Negotiating with Laboratories
- Leveraging Technology for Efficiency
- Optimizing Specimen Handling
- Exploring Alternative Specimen Types
- Considering In-House vs. Outsourced Services
- Focusing on Preventive Care and Early Detection
Verified Providers In Algeria
Navigating the healthcare landscape in Algeria can be a complex task, especially when seeking reliable and accredited medical services. Franance Health stands out as a leading platform dedicated to connecting individuals with verified healthcare providers across Algeria. Our rigorous credentialing process ensures that every provider listed on Franance Health meets the highest standards of professionalism, expertise, and ethical practice. This commitment to quality translates into a superior healthcare experience for our users, offering peace of mind and confidence in the medical care they receive. Choosing a Franance Health-verified provider means opting for transparency, competence, and a patient-centric approach.
| Provider Type | Franance Health Verification Criteria | Benefits for Patients |
|---|---|---|
| Doctors (GPs & Specialists) | Valid medical license, board certifications, proven track record, positive patient feedback, adherence to professional ethics. | Access to competent and experienced medical professionals, accurate diagnoses, effective treatment plans. |
| Hospitals & Clinics | Accreditation from recognized bodies, quality of facilities and equipment, adherence to hygiene standards, patient care protocols, qualified medical staff. | Safe and well-equipped healthcare facilities, comprehensive range of services, attentive patient care. |
| Laboratories & Diagnostic Centers | Accreditation for testing, qualified technicians, use of advanced technology, adherence to quality control measures, timely and accurate results. | Reliable diagnostic testing, precise results, timely identification of health issues. |
| Pharmacies | Valid operating license, qualified pharmacists, adherence to drug dispensing regulations, proper storage of medications, commitment to patient counseling. | Access to safe and legitimate medications, professional advice on drug usage and potential side effects. |
Why Franance Health Credentials Matter:
- Rigorous Verification Process: We go beyond basic licensing to assess qualifications, experience, and adherence to ethical guidelines.
- Focus on Patient Safety: Our credentials prioritize patient well-being and ensure providers operate within established safety protocols.
- Enhanced Trust and Transparency: We provide clear information about provider qualifications, empowering informed decision-making.
- Access to Specialists: Our network includes a wide range of verified specialists, ensuring you find the right expertise for your needs.
- Commitment to Excellence: We continuously monitor and update our verification standards to reflect the evolving healthcare landscape.
Scope Of Work For Histopathology & Cytology
This Scope of Work (SoW) outlines the requirements for the provision of Histopathology and Cytology services. It details the technical deliverables and standard specifications expected from the service provider. The objective is to ensure high-quality diagnostic services that support accurate patient management and treatment.
| Service Area | Technical Deliverables | Standard Specifications | Key Performance Indicators (KPIs) | Reporting Frequency |
|---|---|---|---|---|
| Histopathology Sample Processing and Analysis | Grossing of tissue specimens, embedding in paraffin wax, sectioning, staining (H&E, special stains as required), microscopic examination by qualified pathologists. | Adherence to established protocols for fixation, processing, embedding, sectioning, and staining. Use of calibrated equipment. Availability of a comprehensive menu of special stains. | Turnaround time for routine biopsies (e.g., < 5 working days from receipt). Accuracy rate of diagnoses (e.g., >98%). Percentage of inadequate/unsatisfactory specimens (e.g., <2%). | Daily for critical findings; Weekly for trend analysis. |
| Cytology Sample Processing and Analysis | Preparation of slides from various cytology samples (e.g., fine needle aspirations, exfoliative cytology, body fluids), Papanicolaou staining (Pap smear), Romanowsky staining (e.g., Giemsa), microscopic examination by qualified cytopathologists. | Use of standardized preparation techniques (e.g., ThinPrep, SurePath, conventional smears). Appropriate staining and mounting. Adherence to Bethesda System for reporting cervical cytology. | Turnaround time for urgent cytology (e.g., < 2 working days from receipt). Turnaround time for routine cytology (e.g., < 7 working days from receipt). Sensitivity and specificity of key diagnostic parameters. | Daily for urgent samples; Weekly for routine analysis. |
| Reporting and Interpretation | Provision of comprehensive, clear, and concise histopathology and cytology reports. Reports should include macroscopic and microscopic descriptions, diagnosis, and relevant ancillary studies if performed. | Reports to be generated on approved templates. Inclusion of relevant clinical information. Clear distinction between benign, premalignant, and malignant lesions. Recommendations for further investigations or management when appropriate. | Completeness of reports (e.g., >99%). Clarity and understandability of reports (e.g., assessed via clinician feedback). Availability of electronic reporting. | As per report generation for each case; Summary reports monthly. |
| Quality Assurance and Control | Implementation of a robust Quality Assurance (QA) program including internal and external quality control measures, proficiency testing, and regular audit of results. | Regular calibration and maintenance of all laboratory equipment. Participation in external quality assessment schemes (EQAS) for histopathology and cytology. Internal QC procedures for staining, reagents, and microscopy. | Adherence to accreditation standards (e.g., CAP, ISO 15189). Percentage of participation in EQAS. Number of internal audit findings and their resolution rate. | Monthly review of QA data; Annual audit report. |
| Specimen Handling and Transportation | Receipt, accessioning, tracking, and secure storage of all specimens. Safe and appropriate transportation of specimens to the laboratory. | Use of proper labeling and packaging protocols to prevent misidentification or damage. Maintain chain of custody. Adherence to relevant biohazard and transportation regulations. | Percentage of specimens received without proper identification (e.g., <0.1%). Percentage of specimens damaged during transport (e.g., <0.5%). Timeliness of specimen receipt. | Daily monitoring of specimen integrity; Weekly review of transport logs. |
Key Service Areas
- Histopathology Sample Processing and Analysis
- Cytology Sample Processing and Analysis
- Reporting and Interpretation
- Quality Assurance and Control
- Specimen Handling and Transportation
Service Level Agreement For Histopathology & Cytology
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for the Histopathology & Cytology services provided by [Your Company Name]. This document ensures consistent quality and availability for our clients.
| Service Type | Sample Type | Standard Turnaround Time (TAT) | Critical Sample Turnaround Time (TAT) |
|---|---|---|---|
| Histopathology | Biopsy (Small) | 3-5 Business Days | 1-2 Business Days |
| Histopathology | Biopsy (Large/Complex) | 5-7 Business Days | 2-3 Business Days |
| Histopathology | Surgical Resection | 7-10 Business Days | 3-5 Business Days |
| Cytology | Smear (e.g., Pap, Fluid) | 2-4 Business Days | 1 Business Day |
| Cytology | Fine Needle Aspirate (FNA) | 3-5 Business Days | 2 Business Days |
Key Service Metrics
- Scope: This SLA applies to all standard Histopathology and Cytology diagnostic services.
- Definitions:
- Report Turnaround Time (TAT): The time from sample receipt by the laboratory to the issuance of the final diagnostic report.
- Critical Sample TAT: The time from sample receipt for samples designated as critical to the issuance of the preliminary or final report.
- Uptime: The percentage of time the diagnostic reporting system is available and accessible to authorized users.
- Scheduled Downtime: Planned maintenance periods for system updates or infrastructure upgrades.
- Unscheduled Downtime: Unplanned interruptions to service availability.
- Service Guarantees:
- Standard Reporting: [Your Company Name] guarantees a TAT for standard Histopathology and Cytology reports to be within the specified timeframes. The specific TATs for different sample types are detailed in the 'Reporting Turnaround Times' table.
- Critical Sample Reporting: For samples identified as critical (as per agreed protocols), [Your Company Name] guarantees a reduced TAT, ensuring timely delivery of results for urgent patient care. The specific Critical Sample TATs are outlined in the 'Reporting Turnaround Times' table.
- System Uptime: [Your Company Name] guarantees a minimum system uptime of [e.g., 99.5%] per calendar month, excluding scheduled downtime.
- Exclusions:
- This SLA does not cover delays caused by factors outside of [Your Company Name]'s reasonable control, including but not limited to: extreme weather events, natural disasters, third-party courier delays, or client-side technical issues.
- Delays in sample submission or incomplete documentation from the client.
- Requests for additional testing or consultations that are not part of the initial order.
- Reporting Turnaround Times (TAT):
- The following table outlines the guaranteed turnaround times for Histopathology and Cytology reports. These times are calculated from the point of successful sample receipt by the laboratory and include all necessary processing and diagnostic steps.
- Uptime Guarantees:
- Scheduled Downtime: [Your Company Name] will provide at least [e.g., 48 hours] advance notice for any scheduled downtime. Scheduled downtime will be limited to [e.g., Sundays between 02:00 and 06:00 AM local time] and will be minimized.
- Unscheduled Downtime: In the event of unscheduled downtime, [Your Company Name] will endeavor to restore service as quickly as possible and will provide regular updates on progress. [Your Company Name] commits to a resolution time of [e.g., 4 business hours] for critical system failures.
Frequently Asked Questions
Ready when you are
Let's scope your Histopathology & Cytology in Algeria project in Algeria.
Scaling healthcare logistics and technical systems across the entire continent.